Type 1 diabetes: Prescription of GLP-1 receptor agonists and SGLT2 inhibitors

被引：0
|
作者：
Simon, Annika
机构：
来源：
DIABETOLOGIE UND STOFFWECHSEL | 2025年 / 20卷 / 01期
关键词：
D O I：
10.1055/a-2451-3561
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Two relatively new classes of antidiabetic drugs - GLP-1 receptor agonists (GLP-1-RAs) and SGLT2 inhibitors (SGLT2-Is) - show positive effects on cardiovascular mortality and weight management in people with type 2 diabetes. Since there is also evidence that patients with type 1 diabetes could also benefit, Li et al. conducted a data analysis on current prescribing practices.
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [41] GLP-1 Receptor Agonists and SGLT-2 Inhibitors as Adjuncts to Insulin in Type 1 Diabetes: Benefits and Concerns
    Dimitriadis, George D.
    Lambadiari, Vaia
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (04): : E52 - E53
  • [42] GLP-1 Receptor Agonist and SGLT2 Inhibitor Prescribing in People With Type 1 Diabetes
    Li, Piaopiao
    Li, Zhiyan
    Staton, Elizabeth
    Umpierrez, Guillermo E.
    Davis, Georgia
    Shao, Hui
    Pasquel, Francisco J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024,
  • [43] Comparative Effectiveness of SGLT2 Inhibitors vs. GLP-1 Agonists
    Poonawalla, Insiya
    Bowe, Andy
    Tindal, Michael
    Meah, Yunus A.
    Schwab, Phil
    DIABETES, 2020, 69
  • [44] GLP-1 receptor agonists in comparison with SGLT-2 inhibitors
    Pavlicek, Vojtech
    DIABETOLOGE, 2020, 16 (05): : 530 - 531
  • [45] SGLT2 Inhibitors vs GLP-1 Receptor Agonists and Clinical Outcomes in Patients With Diabetes With/Without Atrial Fibrillation
    Chan, Yi-Hsin
    Chao, Tze-Fan
    Chen, Shao-Wei
    Lee, Hsin-Fu
    Li, Pei-Ru
    Yeh, Yung-Hsin
    Kuo, Chi-Tai
    See, Lai-Chu
    Lip, Gregory Y. H.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (10): : 2617 - 2629
  • [46] Efficacy and safety of GLP-1 receptor agonists as add-on to SGLT2 inhibitors in type 2 diabetes mellitus: A meta-analysis
    Castellana, Marco
    Cignarelli, Angelo
    Brescia, Francesco
    Perrini, Sebastio
    Natalicchio, Annalisa
    Laviola, Luigi
    Giorgino, Francesco
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [47] Efficacy and safety of GLP-1 receptor agonists as add-on to SGLT2 inhibitors in type 2 diabetes mellitus: A meta-analysis
    Marco Castellana
    Angelo Cignarelli
    Francesco Brescia
    Sebastio Perrini
    Annalisa Natalicchio
    Luigi Laviola
    Francesco Giorgino
    Scientific Reports, 9
  • [48] Comparative effectiveness of GLP-1 receptor agonists versus SGLT2 inhibitors in patients with type 2 diabetes and moderate chronic kidney disease
    Rossing, P.
    Fioretto, P.
    Clark, A.
    Jensen, A. B.
    Nazal, N. Belmar
    Tuttle, K. R.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S356 - S357
  • [49] Prescribing Patterns of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Patients With Type 2 Diabetes at Cardiology, Endocrinology, and Primary Care Visits
    Dixon, Dave L.
    Salgado, Teresa M.
    Robinson, Amanda
    Carbone, Salvatore
    Wagner, Tyler D.
    Hyder, Haroon
    Kirschner, Bryan
    Musselman, Kerri T.
    Buffington, Tonya M.
    Sabo, Roy T.
    MAYO CLINIC PROCEEDINGS, 2025, 100 (04) : 647 - 656
  • [50] GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes: Pleiotropic Cardiometabolic Effects and Add-on Value of a Combined Therapy
    Scheen, Andre J.
    DRUGS, 2024, 84 (11) : 1347 - 1364
12345